Newleos Therapeutics’ $93.5 Million Series A Financing Round

Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Newleos Therapeutics in the transaction.Newleos Therapeutics, a clinical stage neuroscience company co-founded by Longwood Fund and seasoned leaders…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here